Resultados de la búsqueda 81-90 of 21538 for Treatment

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Linvoseltamab has previously been studied as a single agent (without other cancer treatments) in participants with multiple myeloma that returned after prior ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, and ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This open-label research study is studying (Z)-endoxifen as a possible treatment for pre-menopausal women with ER+/HER2- breast cancer.

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This open-label research study is studying (Z)-endoxifen as a possible treatment for pre-menopausal women with ER+/HER2- breast cancer.

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6- ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This open-label research study is studying (Z)-endoxifen as a possible treatment for pre-menopausal women with ER+/HER2- breast cancer.

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    (Z)-Endoxifen For The Treatment Of Premenopausal Women With ER+/HER2- Breast Cancer. Scottsdale/Phoenix, Ariz., Jacksonville, Fla., Rochester, Minn. This ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... treatment, post-treatment and (when available) post-mortem soft tissue sarcoma (STS) tissue and tissue data with an emphasis on STSs occurring in younger ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients may receive a single dose to a liver lobe or segmental treatment delivered as a sequence of treatments approximately 30-90 days apart. The ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients may receive a single dose to a liver lobe or segmental treatment delivered as a sequence of treatments approximately 30-90 days apart. The ...